Detailed information for compound 622026

Basic information

Technical information
  • Name: Unnamed compound
  • MW: 400.292 | Formula: C18H14BrN3OS
  • H donors: 1 H acceptors: 3 LogP: 4.35 Rotable bonds: 3
    Rule of 5 violations (Lipinski): 1
  • SMILES: Brc1ccc(cc1)CSc1nc2c3ccccc3nc2c(n1C)O
  • InChi: 1S/C18H14BrN3OS/c1-22-17(23)16-15(13-4-2-3-5-14(13)20-16)21-18(22)24-10-11-6-8-12(19)9-7-11/h2-9,23H,10H2,1H3
  • InChiKey: SCZALBUMXXVDDM-UHFFFAOYSA-N  


Substructure search Similarity search

Network

Hover on a compound node to display the structore

Synonyms

No synonyms found for this compound

Targets

Known targets for this compound

No curated genes were found associated with this compound

Predicted pathogen targets for this compound

By orthology
No druggable targets predicted by orthology data
By sequence similarity to non orthologous known druggable targets
No druggable targets predicted by sequence similarity
Obtained from network model

Ranking Plot

Putative Targets List

Species Potential target Raw Global Species
Trichomonas vaginalis PIKK family atypical protein kinase 0.003 0.0271 0.3593
Trichomonas vaginalis PIKK family atypical protein kinase 0.003 0.0271 0.3593
Trichomonas vaginalis PIKK family atypical protein kinase 0.003 0.0271 0.3593
Trypanosoma brucei phosphatidylinositol 3-kinase, putative 0.003 0.0271 0.8104
Trichomonas vaginalis PIKK family atypical protein kinase 0.003 0.0271 0.3593
Leishmania major hypothetical protein, conserved 0.0032 0.0334 0.0206
Trichomonas vaginalis PIKK family atypical protein kinase 0.003 0.0271 0.3593
Loa Loa (eye worm) phosphatidylinositol 3 0.003 0.0271 0.1545
Mycobacterium tuberculosis Two component sensor histidine kinase DevS 0.0045 0.0637 1
Entamoeba histolytica phosphatidylinositol3-kinaseTor2, putative 0.003 0.0271 0.5
Trichomonas vaginalis PIKK family atypical protein kinase 0.003 0.0271 0.3593
Loa Loa (eye worm) hypothetical protein 0.009 0.1752 1
Schistosoma mansoni cgmp-dependent 35-cyclic phosphodiesterase 0.009 0.1752 1
Loa Loa (eye worm) phosphatidylinositol 3 0.003 0.0271 0.1545
Trichomonas vaginalis PIKK family atypical protein kinase 0.003 0.0271 0.3593
Leishmania major hypothetical protein, conserved 0.0155 0.334 1
Trichomonas vaginalis rod cGMP-specific 3,5-cyclic phosphodiesterase, putative 0.005 0.0753 1
Trypanosoma cruzi GAF domain/TIP41-like family, putative 0.0032 0.0334 0.0216
Trichomonas vaginalis high-affinity cGMP-specific 3,5-cyclic phosphodiesterase, putative 0.0037 0.0451 0.5984
Trichomonas vaginalis PIKK family atypical protein kinase 0.003 0.0271 0.3593
Trichomonas vaginalis PIKK family atypical protein kinase 0.003 0.0271 0.3593
Trichomonas vaginalis PIKK family atypical protein kinase 0.003 0.0271 0.3593
Trichomonas vaginalis PIKK family atypical protein kinase 0.003 0.0271 0.3593
Trichomonas vaginalis PIKK family atypical protein kinase 0.003 0.0271 0.3593
Trypanosoma cruzi GAF domain/TIP41-like family, putative 0.0032 0.0334 0.0216
Echinococcus multilocularis DNA dependent protein kinase catalytic subunit 0.0428 1 1
Brugia malayi 3'5'-cyclic nucleotide phosphodiesterase family protein 0.009 0.1752 1
Trichomonas vaginalis calcium/calmodulin-dependent 3,5-cyclic nucleotide phosphodiesterase, putative 0.005 0.0753 1
Trichomonas vaginalis PIKK family atypical protein kinase 0.003 0.0271 0.3593
Trichomonas vaginalis PIKK family atypical protein kinase 0.003 0.0271 0.3593
Trichomonas vaginalis PIKK family atypical protein kinase 0.003 0.0271 0.3593
Mycobacterium ulcerans two component sensor histidine kinase DevS 0.0045 0.0637 0.5
Trypanosoma brucei Phosphatidylinositol 3-kinase tor1 0.003 0.0271 0.8104
Trichomonas vaginalis PIKK family atypical protein kinase 0.003 0.0271 0.3593
Trichomonas vaginalis PIKK family atypical protein kinase 0.003 0.0271 0.3593
Trichomonas vaginalis PIKK family atypical protein kinase 0.003 0.0271 0.3593
Trypanosoma brucei target of rapamycin kinase 3, putative 0.003 0.0271 0.8104
Trichomonas vaginalis cyclic nucleotide phosphodiesterase, putative 0.005 0.0753 1
Trypanosoma cruzi hypothetical protein, conserved 0.015 0.32 1
Trichomonas vaginalis conserved hypothetical protein 0.005 0.0753 1
Trypanosoma brucei phosphatidylinositol 4-kinase, putative 0.003 0.0271 0.8104
Trypanosoma brucei phosphatidylinositol 3-related kinase, putative 0.003 0.0271 0.8104
Trichomonas vaginalis PIKK family atypical protein kinase 0.003 0.0271 0.3593
Entamoeba histolytica FKBP-rapamycin associated protein (FRAP), putative 0.003 0.0271 0.5
Trichomonas vaginalis high-affinity cGMP-specific 3,5-cyclic phosphodiesterase, putative 0.0037 0.0451 0.5984
Trypanosoma brucei GAF domain/TIP41-like family, putative 0.0032 0.0334 1
Trichomonas vaginalis PIKK family atypical protein kinase 0.003 0.0271 0.3593
Trichomonas vaginalis PIKK family atypical protein kinase 0.003 0.0271 0.3593
Trichomonas vaginalis PIKK family atypical protein kinase 0.003 0.0271 0.3593
Trichomonas vaginalis PIKK family atypical protein kinase 0.003 0.0271 0.3593
Trichomonas vaginalis PIKK family atypical protein kinase 0.003 0.0271 0.3593
Toxoplasma gondii target of rapamycin (TOR), putative 0.003 0.0271 1
Trichomonas vaginalis PIKK family atypical protein kinase 0.003 0.0271 0.3593
Trichomonas vaginalis PIKK family atypical protein kinase 0.003 0.0271 0.3593
Trichomonas vaginalis PIKK family atypical protein kinase 0.003 0.0271 0.3593
Trichomonas vaginalis PIKK family atypical protein kinase 0.003 0.0271 0.3593
Trichomonas vaginalis PIKK family atypical protein kinase 0.003 0.0271 0.3593
Giardia lamblia GTOR 0.003 0.0271 0.5

Activities

No activities found for this compound.

Phenotypes

Whole-cell/tissue/organism interactions

We have no records of whole-cell/tissue assays done with this compound What does this mean?

Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.

Annotated phenotypes:

We have no manually annotated phenotypes for this drug. What does this mean? / Care to help?
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
 
In any case, if you have information about papers containing relevant validation data for this target, please log in using your TDR Targets username and password and send them to us using the corresponding form in this page (only visible to registered users) or contact us.

External resources for this compound

Bibliographic References

No literature references available for this target.

If you have references for this compound, please enter them in a user comment (below) or Contact us.